Product correctly added to cart.

Standards and Solutions in Compliance with Pharmacopoeias
Standards and Solutions in Compliance with Pharmacopoeias

Standards and Solutions in Compliance with Pharmacopoeias

Standards and solutions in compliance with pharmacopoeias are essential reference materials used to ensure the quality, safety, and efficacy of pharmaceutical products. This category includes a wide range of solutions and reagents that adhere to the stringent requirements set forth by various pharmacopoeias, such as the European Pharmacopoeia (EP) and the British Pharmacopoeia (BP). These standards are critical for the calibration and validation of analytical methods, ensuring that pharmaceutical products meet regulatory standards. They support a broad spectrum of applications, including the analysis of active pharmaceutical ingredients (APIs), excipients, and finished drug products. By providing consistent and reliable reference points, these standards and solutions facilitate compliance with regulatory requirements, enhance quality control processes, and ensure the production of safe and effective pharmaceuticals. Their use is indispensable in pharmaceutical research, development, and manufacturing, ensuring that products adhere to the highest quality standards.

Read more

Products of "Standards and Solutions in Compliance with Pharmacopoeias"

Sort by


See more categories

This search does not contain any category.

products per page. 4400 products on this category.

BrandProduct dataPurityPrice rangeEstimated delivery
EDQM - European Pharmacopoeia logo
Bupivacaine impurity D CRS
REF: 41-Y0002384
CAS: 1037184-07-8
- - -115.00 €Tue 07 Jan 25
EDQM - European Pharmacopoeia logo
Sotalol for system suitability CRS
REF: 41-Y0002405
- - -228.00 €Tue 07 Jan 25
EDQM - European Pharmacopoeia logo
Bupivacaine CRS
REF: 41-Y0002387
CAS: 2180-92-9
- - -115.00 €Tue 07 Jan 25
EDQM - European Pharmacopoeia logo
Lonicera japonica flower for peak identification HRS
REF: 41-Y0002396
- - -115.00 €Tue 07 Jan 25
British Pharmacopoeia logo
Ofloxacin
REF: 47-1288
CAS: 82419-36-1
99.3%242.00 €Tue 07 Jan 25
British Pharmacopoeia logo
Levofloxacin hemihydrate
REF: 47-1287
CAS: 138199-71-0
99.2%242.00 €Tue 07 Jan 25
EDQM - European Pharmacopoeia logo
Pimozide for system suitability CRS
REF: 41-Y0002391
CAS: 2062-78-4
- - -115.00 €Tue 07 Jan 25
EDQM - European Pharmacopoeia logo
Trimethoprim for peak identification CRS
REF: 41-Y0002392
- - -115.00 €Tue 07 Jan 25
EDQM - European Pharmacopoeia logo
Pimozide impurity D CRS
REF: 41-Y0002394
- - -115.00 €Tue 07 Jan 25
EDQM - European Pharmacopoeia logo
Phloroglucinol (anhydrous) CRS
REF: 41-Y0000493
CAS: 108-73-6
- - -115.00 €Tue 07 Jan 25
British Pharmacopoeia logo
Enrofloxacin
REF: 47-1286
CAS: 93106-60-6
99.2%242.00 €Tue 07 Jan 25
British Pharmacopoeia logo
Metformin impurity D
REF: 47-1295
CAS: 108-78-1
- - -211.00 €Tue 07 Jan 25
British Pharmacopoeia logo
Salbutamol impurity standard
REF: 47-1309
CAS: 51022-70-9
- - -211.00 €Tue 07 Jan 25
British Pharmacopoeia logo
Salbutamol impurity Q
REF: 47-1308
CAS: 54030-32-9
- - -211.00 €Tue 07 Jan 25
EDQM - European Pharmacopoeia logo
α-tocopheryl acetate for system suitability CRS
REF: 41-Y0002385
CAS: 58-95-7
- - -115.00 €Tue 07 Jan 25
British Pharmacopoeia logo
Lymecycline
REF: 47-218
CAS: 992-21-2
- - -211.00 €Tue 07 Jan 25
British Pharmacopoeia logo
2-carbamoyl-1-methyl-3-[2-(5-methylimidazol-4-ylmethylthio)ethyl]guanidine dihydrochloride
REF: 47-477
CAS: 52568-80-6
- - -211.00 €Tue 07 Jan 25
British Pharmacopoeia logo
Nicotine ditartrate dihydrate
REF: 47-821
CAS: 6019-06-3
92.6% / 32.5%242.00 €Tue 07 Jan 25
British Pharmacopoeia logo
Flumetasone pivalate
REF: 47-1156
CAS: 2002-29-1
99.9%242.00 €Tue 07 Jan 25
British Pharmacopoeia logo
Diphenylmethanol
REF: 47-1119
CAS: 91-01-0
- - -211.00 €Tue 07 Jan 25
discount label

Ref: 41-Y0002384

0.001mg115.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Ref: 41-Y0002405

10mg228.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Ref: 41-Y0002387

20mg115.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Ref: 41-Y0002396

220mg115.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Ofloxacin


Ref: 47-1288

100mg242.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Levofloxacin hemihydrate


Ref: 47-1287

100mg242.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Ref: 41-Y0002391

15mg115.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Ref: 41-Y0002392

1.001mg115.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Ref: 41-Y0002394

0.01mg115.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Phloroglucinol (anhydrous) CRS


Ref: 41-Y0000493

220mg115.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Enrofloxacin


Ref: 47-1286

100mg242.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Metformin impurity D


Ref: 47-1295

10mg211.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Ref: 47-1309

10mg211.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Salbutamol impurity Q


Ref: 47-1308

10mg211.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Ref: 41-Y0002385

100mg115.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Lymecycline


Ref: 47-218

100mg211.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Ref: 47-477

25mg211.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Nicotine ditartrate dihydrate


Ref: 47-821

100mg242.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Flumetasone pivalate


Ref: 47-1156

100mg242.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
discount label

Diphenylmethanol


Ref: 47-1119

25mg211.00 €
Estimated delivery in United States, on Tuesday 7 Jan 2025
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".